Inaxaplin is a small molecule inhibitor of apolipoprotein L1 (APOL1) function, used in research for kidney diseases. It is applied in both in vitro and in vivo studies to investigate APOL1-mediated mechanisms in conditions like focal segmental glomerulosclerosis (FSGS).
Molecular Weight:
417.38
Purity:
99.93% (May vary between batches)
CAS Number:
[2446816-88-0]
Formula:
C21H18F3N3O3
Target:
Others
Application Notes:
Solubility: DMSO:40 mg/mL (95.84 mM)
* VAT and and shipping costs not included. Errors and price changes excepted